AUSTEDO XR TITR(12-18-24-30 MG)
FDA nonproprietary name: deutetrabenazine
For 1 unit (EA)
Pharmacies pay
$249.32 filed
1 × $249.323 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-07-29 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$224.92 filed
1 × $224.9188 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
0.90× estimated
Medicare paid 10% less than pharmacies pay.
Part D averages every strength and form sold under “Austedo XR” / “Deutetrabenazine” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-01-01, 2026-07-29 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$291.72 estimated
$249.32 + $37.40 (15%) + $5.00 fee per fill = $291.72
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-01-01, 2026-07-29 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
AUSTEDO XR TITR(12-18-24-30 MG) is how the CMS NADAC file names this product. The FDA NDC Directory lists it as deutetrabenazine, under the trade name “AUSTEDO XR”.
FDA gives its dosage form as kit.
The labeler, the company named on the label, is Teva Neuroscience, Inc.
FDA lists no Established Pharmacologic Class for it.
The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $249.32 for 1 unit (EA) (1 × $249.323 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-01-01 and 2026-07-29. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 4, carried forward from the previous file.
The NADAC of all 2 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2026-01-01, 2026-07-29. The file is new; the price is not.
What NADAC measures · NADAC explanation codes · Carried-forward prices
All 2 NDCs
- 68546-0477-28 · Teva Neuroscience, Inc. · $249.323 per EA · eff. 2026-07-29 filed carried forward
- 68546-0477-29 · Teva Neuroscience, Inc. · $249.323 per EA · eff. 2026-01-01 filed carried forward
Other strengths, forms and brands
11 other products in the NADAC file share the FDA nonproprietary name deutetrabenazine with AUSTEDO XR TITR(12-18-24-30 MG).
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| AUSTEDO 6 MG TABLET | $83.20001 per EA filed | $103.13655 per EA filed |
| AUSTEDO 9 MG TABLET | $93.97081 per EA filed | $103.13655 per EA filed |
| AUSTEDO 12 MG TABLET | $125.02961 per EA filed | $103.13655 per EA filed |
| AUSTEDO XR 6 MG TABLET | $83.0345 per EA filed | $224.9188 per EA filed |
| AUSTEDO XR 12 MG TABLET | $166.76453 per EA filed | $224.9188 per EA filed |
| AUSTEDO XR 18 MG TABLET | $251.16057 per EA filed | $224.9188 per EA filed |
| AUSTEDO XR 24 MG TABLET | $250.63121 per EA filed | $224.9188 per EA filed |
| AUSTEDO XR 30 MG TABLET | $332.33999 per EA filed | $224.9188 per EA filed |
| AUSTEDO XR 36 MG TABLET | $416.75609 per EA filed | $224.9188 per EA filed |
| AUSTEDO XR 42 MG TABLET | $498.13485 per EA filed | $224.9188 per EA filed |
| AUSTEDO XR 48 MG TABLET | $500.84367 per EA filed | $224.9188 per EA filed |
| AUSTEDO XR TITR(12-18-24-30 MG) this page | $249.323 per EA filed | $224.9188 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-07-29, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
What Medicare paid
Medicare Part D paid $224.92 for 1 unit (EA), at an average of $224.9188 per EA in 2024 (2024-01-01 to 2024-12-31) for “Austedo XR” and “Deutetrabenazine”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 81,595 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 1 unit (EA)? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for AUSTEDO XR TITR(12-18-24-30 MG) labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Austedo XR / Deutetrabenazine: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.
- Why does this page start at 1 unit (EA)?
- NADAC prices this product per EA, and the FDA NDC Directory lists its 2 NDCs as dosage form “KIT” with no route. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and none of these is one. NADAC’s EA for it may be the whole kit or one item in it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.